Zurich Cantonal Bank
XENE icon

Zurich Cantonal Bank’s Xenon Pharmaceuticals XENE Stock Holding History

Zurich Cantonal Bank’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Buy
44,096
+8,892
+25% +$494K 0.01% 973
2026
Q1 		$2.05M Buy
35,204
+9,615
+38% +$443K ﹤0.01% 1034
2025
Q4 		$1.15M Hold
25,589
– – ﹤0.01% 1263
2025
Q3 		$1.03M Buy
25,589
+1,723
+7% +$60.7K ﹤0.01% 1269
2025
Q2 		$747K Buy
23,866
+4,910
+26% +$160K ﹤0.01% 1410
2025
Q1 		$636K Sell
18,956
-318
-2% -$12.1K ﹤0.01% 1441
2024
Q4 		$756K Buy
19,274
+2,866
+17% +$118K ﹤0.01% 1377
2024
Q3 		$646K Sell
16,408
-8
-0% -$323 ﹤0.01% 1391
2024
Q2 		$640K Sell
16,416
-14,864
-48% -$594K ﹤0.01% 1315
2024
Q1 		$1.35M Buy
31,280
+15,696
+101% +$722K ﹤0.01% 914
2023
Q4 		$718K Buy
15,584
+3,961
+34% +$140K ﹤0.01% 1256
2023
Q3 		$397K Buy
11,623
+2,430
+26% +$90.9K ﹤0.01% 1533
2023
Q2 		$354K Sell
9,193
-114
-1% -$4.53K ﹤0.01% 1560
2023
Q1 		$333K Sell
9,307
-132
-1% -$4.88K ﹤0.01% 1549
2022
Q4 		$372K Buy
9,439
+2,772
+42% +$101K ﹤0.01% 1425
2022
Q3 		$241K Hold
6,667
– – ﹤0.01% 1635
2022
Q2 		$203K Sell
6,667
-66
-1% -$2K ﹤0.01% 1784
2022
Q1 		$206K Sell
6,733
-2,832
-30% -$84.8K ﹤0.01% 1863
2021
Q4 		$299K Buy
9,565
+5,364
+128% +$160K ﹤0.01% 1812
2021
Q3 		$64K Buy
4,201
+110
+3% +$1.91K ﹤0.01% 2546
2021
Q2 		$76K Hold
4,091
– – ﹤0.01% 2331
2021
Q1 		$73K Buy
+4,091
New +$69.3K ﹤0.01% 2280

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Zurich Cantonal Bank's XENE Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Xenon Pharmaceuticals (XENE) stake by 25% in Q2 2026, buying an estimated $494K and bringing the position to 44,096 shares worth $2.66M. The position accounts for 0.01% of the portfolio, ranked #973.

Zurich Cantonal Bank first reported a position in XENE in Q1 2021 and has held it in 22 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Zurich Cantonal Bank held 44,096 shares of Xenon Pharmaceuticals worth $2.66M as of Q2 2026.
  • Zurich Cantonal Bank bought 8,892 Xenon Pharmaceuticals shares in Q2 2026, an estimated $494K.
  • Xenon Pharmaceuticals made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #973 holding.
  • Zurich Cantonal Bank first reported a position in Xenon Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.